Cardiovascular risk stratification in asymptomatic individuals in Bitola, North Macedonia by using High sensitive Troponin I Assay

[eng] Objectives: The aim of our prospective cohort study in Macedonia was to evaluate the distribution of hs-cTnI concentrations in health individuals to stratified cardiovascular risk. Background: The latest generations of hs-cTnI could be used for the stratification of cardiovas...

ver descrição completa

Detalhes bibliográficos
Autores: Ilkovska, Biljana, Trifunova, Bisera Kotevska, Avramovski, Petar
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2023
País:España
Recursos:Universidad de las Islas Baleares
Repositorio:Biblioteca Digital de les Illes Balears
OAI Identifier:medicinaBalear:AJHS_Medicina_Balear_2023v38n2p104
Acesso em linha:http://ibdigital.uib.es/greenstone/sites/oai-site/collect/medicinaBalear/index/assoc/AJHS_Med/icina_Ba/lear_202/3v38n2p1/04.dir/AJHS_Medicina_Balear_2023v38n2p104.pdf
http://ibdigital.uib.es/greenstone/library/collection/medicinaBalear/document/AJHS_Medicina_Balear_2023v38n2p104
Access Level:acceso abierto
Palavra-chave:Cardiovascular system -- Diseases
Health Sciences
id ES_2db2b03dffe2a3b5717c1c9f0b83cead
oai_identifier_str medicinaBalear:AJHS_Medicina_Balear_2023v38n2p104
network_acronym_str ES
network_name_str España
repository_id_str
spelling Cardiovascular risk stratification in asymptomatic individuals in Bitola, North Macedonia by using High sensitive Troponin I Assay Ilkovska, BiljanaTrifunova, Bisera KotevskaAvramovski, PetarCardiovascular system -- DiseasesHealth Sciences[eng] Objectives: The aim of our prospective cohort study in Macedonia was to evaluate the distribution of hs-cTnI concentrations in health individuals to stratified cardiovascular risk. Background: The latest generations of hs-cTnI could be used for the stratification of cardiovascular risk in the general population, using values within the normal range. Methods: Study was performed from one year period in 2021 year. We measured hs-cTnI concentrations in 1201 participants 690 males and 511 females by using Abbott Architect analyzer. Results: We found that elevated risk for cardiovascular event is higher in males compared to females, also we confirm that risk of cardiovascular events increase significantly with age in both sexes, but is predominant in males. Conclusion: The hs-cTnI assay provides detection of troponin in a significant proportion of asymptomatic individuals. Hs-cTnI allows us to act preventively in patients at increased risk by including statin therapy, weight regulation or lifestyle changes, intensifying physical activity, while its values are parallel to the modification of cardiovascular risk. Patients should be informed that there is a possibility of cardiovascular risk assessment and more massive hs-cTnI examination.[spa] Objetivos: El objetivo de nuestro estudio de cohorte prospectivo en Macedonia fue evaluar la distribución de las concentraciones de hs-cTnI en individuos sanos para estratificar el riesgo cardiovascular. Antecedentes: Las últimas generaciones de hs-cTnI podrían utilizarse para la estratificación del riesgo cardiovascular en la población general, utilizando valores dentro del rango normal. Métodos: El estudio se realizó durante un período de un año en 2021. Se midieron las concentraciones de hs-cTnI en 1201 participantes, 690 hombres y 511 mujeres, utilizando el analizador Abbott Architect. Resultados: Encontramos que el riesgo elevado de eventos cardiovasculares es mayor en los hombres en comparación con las mujeres, también confirmamos que el riesgo de eventos cardiovasculares aumenta significativamente con la edad en ambos sexos, pero es predominante en los hombres. Conclusión: El ensayo hs-cTnI proporciona la detección de troponina en una proporción significativa de individuos asintomáticos. La Hs-cTnI permite actuar de forma preventiva en los pacientes con riesgo aumentado incluyendo el tratamiento con estatinas, la regulación del peso o los cambios en el estilo de vida, intensificando la actividad física, mientras que sus valores son paralelos a la modificación del riesgo cardiovascular. Se debe informar a los pacientes que existe la posibilidad de evaluar el riesgo cardiovascular y realizar un examen más masivo de hs-cTnI.Reial Acadèmia de Medicina de les Illes Balears2023info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttp://ibdigital.uib.es/greenstone/sites/oai-site/collect/medicinaBalear/index/assoc/AJHS_Med/icina_Ba/lear_202/3v38n2p1/04.dir/AJHS_Medicina_Balear_2023v38n2p104.pdfhttp://ibdigital.uib.es/greenstone/library/collection/medicinaBalear/document/AJHS_Medicina_Balear_2023v38n2p104reponame:Biblioteca Digital de les Illes Balearsinstname:Universidad de las Islas BalearesInglésAcademic Journal of Health Sciences 2023, Vol. 38, n. 2, pp. 104-109All rights reservedinfo:eu-repo/semantics/openAccessmedicinaBalear:AJHS_Medicina_Balear_2023v38n2p1042026-05-28T12:40:11Z
dc.title.none.fl_str_mv Cardiovascular risk stratification in asymptomatic individuals in Bitola, North Macedonia by using High sensitive Troponin I Assay
title Cardiovascular risk stratification in asymptomatic individuals in Bitola, North Macedonia by using High sensitive Troponin I Assay
spellingShingle Cardiovascular risk stratification in asymptomatic individuals in Bitola, North Macedonia by using High sensitive Troponin I Assay
Ilkovska, Biljana
Cardiovascular system -- Diseases
Health Sciences
title_short Cardiovascular risk stratification in asymptomatic individuals in Bitola, North Macedonia by using High sensitive Troponin I Assay
title_full Cardiovascular risk stratification in asymptomatic individuals in Bitola, North Macedonia by using High sensitive Troponin I Assay
title_fullStr Cardiovascular risk stratification in asymptomatic individuals in Bitola, North Macedonia by using High sensitive Troponin I Assay
title_full_unstemmed Cardiovascular risk stratification in asymptomatic individuals in Bitola, North Macedonia by using High sensitive Troponin I Assay
title_sort Cardiovascular risk stratification in asymptomatic individuals in Bitola, North Macedonia by using High sensitive Troponin I Assay
dc.creator.none.fl_str_mv Ilkovska, Biljana
Trifunova, Bisera Kotevska
Avramovski, Petar
author Ilkovska, Biljana
author_facet Ilkovska, Biljana
Trifunova, Bisera Kotevska
Avramovski, Petar
author_role author
author2 Trifunova, Bisera Kotevska
Avramovski, Petar
author2_role author
author
dc.subject.none.fl_str_mv Cardiovascular system -- Diseases
Health Sciences
topic Cardiovascular system -- Diseases
Health Sciences
description [eng] Objectives: The aim of our prospective cohort study in Macedonia was to evaluate the distribution of hs-cTnI concentrations in health individuals to stratified cardiovascular risk. Background: The latest generations of hs-cTnI could be used for the stratification of cardiovascular risk in the general population, using values within the normal range. Methods: Study was performed from one year period in 2021 year. We measured hs-cTnI concentrations in 1201 participants 690 males and 511 females by using Abbott Architect analyzer. Results: We found that elevated risk for cardiovascular event is higher in males compared to females, also we confirm that risk of cardiovascular events increase significantly with age in both sexes, but is predominant in males. Conclusion: The hs-cTnI assay provides detection of troponin in a significant proportion of asymptomatic individuals. Hs-cTnI allows us to act preventively in patients at increased risk by including statin therapy, weight regulation or lifestyle changes, intensifying physical activity, while its values are parallel to the modification of cardiovascular risk. Patients should be informed that there is a possibility of cardiovascular risk assessment and more massive hs-cTnI examination.
publishDate 2023
dc.date.none.fl_str_mv 2023
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://ibdigital.uib.es/greenstone/sites/oai-site/collect/medicinaBalear/index/assoc/AJHS_Med/icina_Ba/lear_202/3v38n2p1/04.dir/AJHS_Medicina_Balear_2023v38n2p104.pdf
http://ibdigital.uib.es/greenstone/library/collection/medicinaBalear/document/AJHS_Medicina_Balear_2023v38n2p104
url http://ibdigital.uib.es/greenstone/sites/oai-site/collect/medicinaBalear/index/assoc/AJHS_Med/icina_Ba/lear_202/3v38n2p1/04.dir/AJHS_Medicina_Balear_2023v38n2p104.pdf
http://ibdigital.uib.es/greenstone/library/collection/medicinaBalear/document/AJHS_Medicina_Balear_2023v38n2p104
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Academic Journal of Health Sciences 2023, Vol. 38, n. 2, pp. 104-109
dc.rights.none.fl_str_mv All rights reserved
info:eu-repo/semantics/openAccess
rights_invalid_str_mv All rights reserved
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Reial Acadèmia de Medicina de les Illes Balears
publisher.none.fl_str_mv Reial Acadèmia de Medicina de les Illes Balears
dc.source.none.fl_str_mv reponame:Biblioteca Digital de les Illes Balears
instname:Universidad de las Islas Baleares
instname_str Universidad de las Islas Baleares
reponame_str Biblioteca Digital de les Illes Balears
collection Biblioteca Digital de les Illes Balears
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869405343119835136
score 15,300719

Registos relacionados